The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 6 , Pages 1400-1405 , June 2009

Lobectomy with pulmonary artery resection: Morbidity, mortality, and long-term survival

  • Marco Alifano, MD

      Affiliations

    • Department of Thoracic Surgery, Hôtel Dieu Hospital, AP-HP, Paris, France
    • Corresponding Author InformationAddress for reprints: Marco Alifano, MD, Unité de Chirurgie Thoracique, Hôtel Dieu, 1, Place du Parvis Notre-Dame, 75181 Paris Cedex, France .
    • ,
  • Giacomo Cusumano, MD

      Affiliations

    • Department of Thoracic Surgery, Hôtel Dieu Hospital, AP-HP, Paris, France
    • ,
  • Salvatore Strano, MD

      Affiliations

    • Department of Thoracic Surgery, Hôtel Dieu Hospital, AP-HP, Paris, France
    • ,
  • Pierre Magdeleinat, MD

      Affiliations

    • Department of Thoracic Surgery, Hôtel Dieu Hospital, AP-HP, Paris, France
    • ,
  • Antonio Bobbio, MD

      Affiliations

    • Department of Thoracic Surgery, Hôtel Dieu Hospital, AP-HP, Paris, France
    • ,
  • Frederique Giraud, MD

      Affiliations

    • Department of Pneumology, Hôtel Dieu Hospital, AP-HP, Paris, France
    • ,
  • Bernard Lebeau, MD

      Affiliations

    • Department of Pneumology, St Antoine Hospital, AP-HP, Paris, France
    • ,
  • Jean-François Régnard, MD

      Affiliations

    • Department of Thoracic Surgery, Hôtel Dieu Hospital, AP-HP, Paris, France

Received 30 April 2008 ,Revised 11 September 2008 ,Accepted 2 November 2008.

  • Image Result

    Survival according to tumor size in patients with non–small cell lung cancer. Patients with tumors smaller than 3 cm had significantly (P = .027) better 5-year survival than the remaining patients (47

    Survival according to tumor size in patients with non–small cell lung cancer. Patients with tumors smaller than 3 cm had significantly (P = .027) better 5-year survival than the remaining patients (47.9% [95% confidence interval, 25.8%–68.0%] vs 26.1% [95% confidence interval, 13.6%–44.2%]).

  • Image Result
    Survival according to peritumoral and intratumoral vascular emboli in patients with non–small cell lung cancer. The presence of peritumoral, intratumoral, or both neoplastic vascular emboli was associ

    Survival according to peritumoral and intratumoral vascular emboli in patients with non–small cell lung cancer. The presence of peritumoral, intratumoral, or both neoplastic vascular emboli was associated with significantly (P = .0068) worse 5-year survival (23.6% [95% confidence interval, 10.6%–44.4%] vs 43.1% [95% confidence interval, 26.7%–61.2%]).

PII: S0022-5223(08)01941-7

doi: 10.1016/j.jtcvs.2008.11.002

The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 6 , Pages 1400-1405 , June 2009

Article Tools

* Image Usage & Resolution